Thus, immunodeficient rodents used for the heterotopic propagation and serial passaging of GBM can be considered as reservoirs for providing a continuing supply of the same tumor for establishing orthotopic model that retains the EGFR gene alteration when compared with previous reported methods (34, 35). The gene discussed is EGFR; the disease is glioblastoma.